Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Minimal Disease, Residual

bromocriptine has been researched along with Minimal Disease, Residual in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenman, Y; Osher, E; Ouaknine, G; Reider-Groswasser, II; Segev, Y; Shenkerman, G; Stern, N; Tordjman, K; Veshchev, I1
Benveniste, RJ; Delman, BN; King, WA; Lee, JS; Post, KD; Walsh, J1
Black, PM; Garber, JR; Glickman, JN; Lidov, HG; McCowen, KC; Zervas, NT1

Other Studies

3 other study(ies) available for bromocriptine and Minimal Disease, Residual

ArticleYear
Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
    Clinical endocrinology, 2005, Volume: 63, Issue:1

    Topics: Adenoma; Adult; Aged; Bromocriptine; Cohort Studies; Dopamine Agonists; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Pituitary Neoplasms; Postoperative Period; Survival Analysis; Thyrotropin-Releasing Hormone; Treatment Outcome

2005
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
    Journal of neurosurgery, 2005, Volume: 102, Issue:6

    Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Postoperative Complications; Predictive Value of Tests; Radiotherapy; Reoperation; Retrospective Studies; Sphenoid Bone; Treatment Outcome

2005
Gangliocytoma masquerading as a prolactinoma. Case report.
    Journal of neurosurgery, 1999, Volume: 91, Issue:3

    Topics: Adult; Bromocriptine; Diagnosis, Differential; Follow-Up Studies; Ganglioneuroma; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Neurofilament Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Synaptophysin; Temporal Lobe

1999